Will detection of microRNA biomarkers in blood improve the diagnosis and survival of patients with pancreatic cancer?
JAMA
.
2014 Jan;311(4):363-5.
doi: 10.1001/jama.2013.284665.
Authors
Donald J Buchsbaum
1
,
Carlo M Croce
2
Affiliations
1
Division of Radiation Biology, Department of Radiation Oncology, University of Alabama, Birmingham.
2
Comprehensive Cancer Center, Department of Molecular Virology, Immunology and Medical Genetics, Ohio State University, Columbus.
PMID:
24449314
PMCID:
PMC4161014
DOI:
10.1001/jama.2013.284665
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Comment
MeSH terms
Female
Humans
Male
MicroRNAs / blood*
Pancreatic Neoplasms / diagnosis*
Pancreatitis, Chronic / diagnosis*
Substances
MicroRNAs
Grants and funding
P20 CA101955/CA/NCI NIH HHS/United States
P50 CA101955/CA/NCI NIH HHS/United States
U01 CA152758/CA/NCI NIH HHS/United States